Skip to main content
Clinical Trials/NCT05162716
NCT05162716
Unknown
N/A

Cardiac ResynchrOniSation Via Stimulation of the LEFT Bundle in AF Patients.

Nicolas Clementy, MD, PhD1 site in 1 country50 target enrollmentMay 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pacing-Induced Cardiomyopathy
Sponsor
Nicolas Clementy, MD, PhD
Enrollment
50
Locations
1
Primary Endpoint
Heart failure hospitalization
Last Updated
4 years ago

Overview

Brief Summary

Permanent ventricular pacing may be complicated with ventricular dyssynchrony and subsequent pacing-induced cardiomyopathy. We hypothesized that left bundle branch area pacing may prevent the development of pacing-induced cardiomyopathy in patients with permanent atrial fibrillation requiring permanent ventricular pacing.

Patients with permanent atrial arrhythmia with an indication of cardiac pacing and atrioventricular junction ablation will be prospectively enrolled.

They will undergo the implantation of a single-chamber pacemaker with left bundle branch area pacing, and then atrioventricular junction ablation.

They will be prospectively followed during 6 months.

Detailed Description

Patients with permanent atrial arrhythmia with an indication of cardiac pacing and atrioventricular junction ablation will be prospectively enrolled. They will undergo the implantation of a single-chamber pacemaker with left bundle branch area pacing confirmed according to electrocardiographic parameters. Atrioventricular node ablation will be performed the following day through a femoral venous approach. Perioperative data and potential complications will be collected. Patients will be prospectively followed during 6 months. They will have clinical examination, 12-lead ECG, and an echocardiography.

Registry
clinicaltrials.gov
Start Date
May 1, 2020
End Date
October 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Nicolas Clementy, MD, PhD
Responsible Party
Sponsor Investigator
Principal Investigator

Nicolas Clementy, MD, PhD

Associate Professor

University Hospital, Tours

Eligibility Criteria

Inclusion Criteria

  • Permanent atrial arrhythmia
  • Symptoms related to an insufficient rate control under optimal medical therapy

Exclusion Criteria

  • Indication of prophylactic defibrillator
  • Already implanted with a cardiac device

Outcomes

Primary Outcomes

Heart failure hospitalization

Time Frame: 6 months

Hospitalization for decompensated heart failure

Secondary Outcomes

  • Complications(30 days)
  • Mortality(6 months)
  • Electrical remodeling(6 months)
  • Volumetric response(6 months)

Study Sites (1)

Loading locations...

Similar Trials